MAPK14 and lung cancer: Network analysis and metabolomics combined with western blot demonstrated that GYP might exert anti-lung cancer effects as well as enhance the pharmacological effects of the chemotherapeutic agent cisplatin through the MAPK14/STAT3 signaling pathway.